David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
CALL
Intuit
INTU
$97.8B
| $1.04M | ﹤0.01% |
10,000
-85,400
| -90% | -$8.25M |
|
2302
SLR Investment Corp
SLRC
$687M
| $1.03M | ﹤0.01% |
59,880
+25,322
| +73% | +$423K |
|
|
WLB
2303
DELISTED
Westmoreland Coal Company
WLB
| $1.03M | ﹤0.01% |
+143,200
| New | +$852K |
|
2304
National Bank Holdings
NBHC
$1.84B
| $1.03M | ﹤0.01% |
50,476
-29,255
| -37% | -$579K |
|
2305
PDF Solutions
PDFS
$1.87B
| $1.03M | ﹤0.01% |
76,830
-23,838
| -24% | -$261K |
|
|
STL
2306
DELISTED
Sterling Bancorp
STL
| $1.03M | ﹤0.01% |
64,456
+43,520
| +208% | +$659K |
|
2307
CALL
Royal Gold
RGLD
$22.7B
| $1.03M | ﹤0.01% |
20,000
-9,900
| -33% | -$404K |
|
2308
CALL
American Tower
AMT
$83.2B
| $1.02M | ﹤0.01% |
10,000
-147,800
| -94% | -$13.8M |
|
|
FSP
2309
Franklin Street Properties
FSP
$45.5M
| $1.02M | ﹤0.01% |
96,408
+9,599
| +11% | +$93.3K |
|
2310
Silicom
SILC
$249M
| $1.02M | ﹤0.01% |
29,895
-13,630
| -31% | -$410K |
|
2311
Boot Barn
BOOT
$4.84B
| $1.02M | ﹤0.01% |
+108,443
| New | +$968K |
|
2312
Asbury Automotive
ABG
$3.87B
| $1.02M | ﹤0.01% |
17,000
-33,375
| -66% | -$1.82M |
|
2313
Rush Enterprises Class A
RUSHA
$8.36B
| $1.01M | ﹤0.01% |
124,803
+41,607
| +50% | +$335K |
|
|
TRUE
2314
DELISTED
TrueCar
TRUE
| $1.01M | ﹤0.01% |
180,998
+132,479
| +273% | +$800K |
|
|
RDS.A
2315
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.01M | ﹤0.01% |
22,021
-17,773
| -45% | -$753K |
|
|
SGNT
2316
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.01M | ﹤0.01% |
83,071
+51,917
| +167% | +$728K |
|
|
KYO
2317
DELISTED
Kyocera Adr
KYO
| $1.01M | ﹤0.01% |
22,869
+1,489
| +7% | +$64.5K |
|
2318
Super Micro Computer
SMCI
$24.9B
| $1.01M | ﹤0.01% |
+296,000
| New | +$886K |
|
|
ZGNX
2319
DELISTED
Zogenix, Inc.
ZGNX
| $1.01M | ﹤0.01% |
109,121
-196,080
| -64% | -$1.96M |
|
2320
Lexicon Pharmaceuticals
LXRX
$1.04B
| $1.01M | ﹤0.01% |
84,300
+64,991
| +337% | +$681K |
|
|
DSCI
2321
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $1.01M | ﹤0.01% |
324,713
+23,591
| +8% | +$79K |
|
|
CORR
2322
PUT
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.01M | ﹤0.01% |
+50,000
| New | +$753K |
|
2323
Dover
DOV
$27.2B
| $1M | ﹤0.01% |
+19,302
| New | +$936K |
|
2324
Teekay Tankers
TNK
$3.12B
| $1M | ﹤0.01% |
34,098
+21,252
| +165% | +$733K |
|
2325
Pearson
PSO
$9.98B
| $1M | ﹤0.01% |
79,790
-51,686
| -39% | -$591K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.